↓ Skip to main content

Pericardial syndromes: an update after the ESC guidelines 2004

Overview of attention for article published in Heart Failure Reviews, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
139 Mendeley
Title
Pericardial syndromes: an update after the ESC guidelines 2004
Published in
Heart Failure Reviews, August 2012
DOI 10.1007/s10741-012-9335-x
Pubmed ID
Authors

Petar M. Seferović, Arsen D. Ristić, Ružica Maksimović, Dejan S. Simeunović, Ivan Milinković, Jelena P. Seferović Mitrović, Vladimir Kanjuh, Sabine Pankuweit, Bernhard Maisch

Abstract

Despite a myriad of causes, pericardial diseases present in few clinical syndromes. Acute pericarditis should be differentiated from aortic dissection, myocardial infarction, pneumonia/pleuritis, pulmonary embolism, pneumothorax, costochondritis, gastroesophageal reflux/neoplasm, and herpes zoster. High-risk features indicating hospitalization are: fever >38 °C, subacute onset, large effusion/tamponade, failure of non-steroidal anti-inflammatory drugs (NSAIDs), previous immunosuppression, trauma, anticoagulation, neoplasm, and myopericarditis. Treatment comprises 10-14-days NSAID plus 3 months colchicine (2 × 0.5 mg; 1 × 0.5 mg in patients <70 kg). Corticosteroids are avoided, except for autoimmunity, as they facilitate the recurrences. Echo-guided pericardiocentesis (±fluoroscopy) is indicated for tamponade and effusions >2 cm. Smaller effusions are drained if neoplastic, purulent or tuberculous etiology is suspected. In recurrent pericarditis, repeated testing for autoimmune and thyroid disease is appropriate. Pericardioscopy and pericardial/epicardial biopsy may clarify the etiology. Familial clustering was recently associated with tumor necrosis factor receptor-associated periodic syndrome (TNFRSF1A gene mutation). Treatment includes 10-14 days NSAIDs with colchicine 0.5 mg bid for up to 6 months. In non-responders, low-dose steroids, intrapericardial steroids, azathioprine, and cyclophosphamide can be tried. Successful management with interleukin-1 receptor antagonist (anakinra) was recently reported. Pericardiectomy remains the last option in >2 years severely symptomatic patients. In constriction, expansion of the heart is impaired by the rigid, chronically inflamed/thickened pericardium (no thickening ~20 %). Chest radiography, echocardiography, computerized tomography, magnetic resonance imaging, hemodynamics, and endomyocardial biopsy indicate the diagnosis. Pericardiectomy is the only treatment for permanent constriction. Predictors of poor survival are prior radiation, renal dysfunction, high pulmonary artery pressures, poor left ventricular function, hyponatremia, age, and simultaneous HIV and tuberculous infection.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 2 1%
Hungary 1 <1%
United States 1 <1%
Unknown 135 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 15%
Other 20 14%
Student > Master 19 14%
Student > Bachelor 18 13%
Student > Postgraduate 14 10%
Other 31 22%
Unknown 16 12%
Readers by discipline Count As %
Medicine and Dentistry 94 68%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Nursing and Health Professions 4 3%
Agricultural and Biological Sciences 3 2%
Neuroscience 3 2%
Other 9 6%
Unknown 22 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2020.
All research outputs
#7,453,126
of 22,785,242 outputs
Outputs from Heart Failure Reviews
#227
of 667 outputs
Outputs of similar age
#54,761
of 164,901 outputs
Outputs of similar age from Heart Failure Reviews
#2
of 7 outputs
Altmetric has tracked 22,785,242 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 667 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,901 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.